These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30831307)

  • 1. PHARMECMO: Therapeutic drug monitoring and adequacy of current dosing regimens of antibiotics in patients on Extracorporeal Life Support.
    Bouglé A; Dujardin O; Lepère V; Ait Hamou N; Vidal C; Lebreton G; Salem JE; El-Helali N; Petijean G; Amour J
    Anaesth Crit Care Pain Med; 2019 Oct; 38(5):493-497. PubMed ID: 30831307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.
    Kühn D; Metz C; Seiler F; Wehrfritz H; Roth S; Alqudrah M; Becker A; Bracht H; Wagenpfeil S; Hoffmann M; Bals R; Hübner U; Geisel J; Lepper PM; Becker SL
    Crit Care; 2020 Nov; 24(1):664. PubMed ID: 33239110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTAC: Optimization of Antibiotic Therapy in Critically ill Patients. Using beta-lactam antibiotics by continuous infusion.
    Esteve-Pitarch E; Padullés-Zamora A; Maisterra-Santos K; Colom-Codina H; Cobo-Sacristán S
    Farm Hosp; 2019 Sep; 43(5):151-157. PubMed ID: 31469627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of cefepime in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Jakob SM; Levkovich BJ; Pellegrino V; Que YA; Reynolds C; Rudham S; Wallis SC; Welch SA; Zacharias D; Roberts JA; Shekar K; Fraser JF
    Int J Antimicrob Agents; 2021 Dec; 58(6):106466. PubMed ID: 34688834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of therapeutic drug monitoring of piperacillin and meropenem in routine clinical practice: a prospective cohort study in critically ill patients.
    Schoenenberger-Arnaiz JA; Ahmad-Diaz F; Miralbes-Torner M; Aragones-Eroles A; Cano-Marron M; Palomar-Martinez M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e30-e35. PubMed ID: 32296502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics and pharmacodynamics of antibiotics in septic children treated with extracorporeal membrane oxygenation].
    Zhang HX; Huang JT; Dong J; Gong TZ; Zhang KY; Lu XL; Guo SW
    Zhonghua Er Ke Za Zhi; 2023 Jul; 61(7):631-636. PubMed ID: 37385807
    [No Abstract]   [Full Text] [Related]  

  • 7. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
    van Maarseveen EM; Sprij A; Touw DJ
    Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
    Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
    Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.
    Touchard C; Aubry A; Eloy P; Bréchot N; Lebreton G; Franchineau G; Besset S; Hékimian G; Nieszkowska A; Leprince P; Luyt CE; Combes A; Schmidt M
    Crit Care; 2018 Aug; 22(1):199. PubMed ID: 30121083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of meropenem in children with sepsis undergoing extracorporeal life support: A prospective observational study.
    Wang Y; Li Z; Chen W; Yan G; Wang G; Lu G; Chen C
    J Clin Pharm Ther; 2021 Jun; 46(3):754-761. PubMed ID: 33476064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmatic concentracion of piperacillin/tazobactam in pediatric patients on ECMO support. Preliminary analysis].
    Zylbersztajn B; Izquierdo C G; Navea M D; Torres T JP; Valverde G C
    Rev Chilena Infectol; 2020 Jun; 37(3):216-218. PubMed ID: 32853311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of amikacin in septic patients.
    Duszynska W; Taccone FS; Hurkacz M; Kowalska-Krochmal B; Wiela-Hojeńska A; Kübler A
    Crit Care; 2013 Jul; 17(4):R165. PubMed ID: 23886243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study.
    Donadello K; Antonucci E; Cristallini S; Roberts JA; Beumier M; Scolletta S; Jacobs F; Rondelet B; de Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2015 Mar; 45(3):278-82. PubMed ID: 25542059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.
    Fillâtre P; Lemaitre F; Nesseler N; Schmidt M; Besset S; Launey Y; Maamar A; Daufresne P; Flecher E; Le Tulzo Y; Tadie JM; Tattevin P
    J Antimicrob Chemother; 2021 Apr; 76(5):1242-1249. PubMed ID: 33569597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?
    Roberts JA; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    Crit Care Med; 2009 Mar; 37(3):926-33. PubMed ID: 19237898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring-guided continuous infusion of piperacillin/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: a retrospective analysis of four years of clinical experience.
    Richter DC; Frey O; Röhr A; Roberts JA; Köberer A; Fuchs T; Papadimas N; Heinzel-Gutenbrunner M; Brenner T; Lichtenstern C; Weigand MA; Brinkmann A
    Infection; 2019 Dec; 47(6):1001-1011. PubMed ID: 31473974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pharmacokinetic/pharmacodynamic and clinical outcomes with 6-hourly empiric piperacillin-tazobactam dosing in hematological malignancy patients with febrile neutropenia.
    Weber N; Jackson K; McWhinney B; Ungerer J; Kennedy G; Lipman J; Roberts JA
    J Infect Chemother; 2019 Jul; 25(7):503-508. PubMed ID: 30879981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.
    Ben Romdhane H; Ben Fredj N; Chaabane A; Ben Aicha S; Chadly Z; Ben Fadhel N; Boughattas N; Aouam K
    Nephrol Ther; 2019 Apr; 15(2):110-114. PubMed ID: 30660586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.